September 28, 2026 · Phase 3 readout
KOD Phase 3 readout: a positive outcome, +163.5%
+163.5%Kodiak Sciences Inc (KOD) →
On September 28, 2026, KSI-101 — Kodiak Sciences Inc (Macular Edema Secondary to Inflammation) reached its Phase 3 readout. The result was a positive outcome, and the stock moved +163.5% in the window around the event. It had already run -14.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$32.35
1d before
$85.23
Event day
$85.23
1d after
$85.23
5d after
Our prediction vs. the result
CatalystAlert called this one up (+6.3% expected); the stock actually moved +163.5%. Model confidence at the time: 60%.
See the full scored track recordPre-catalyst setup
-14.2%
30-day run-up
4295%
30-day volatility
2.8×
volume spike